CFTR and hydrops fetalis: Supportive of this paradigm are our findings showing that therapeutic CFTR correction attenuates the HF-associated elevation of systemic and pulmonary S1P concentrations, reduces the frequency of S1P1 positivity on immune cells and, hence, lowers the percentage of lung infiltrating immune cells.